Back to News
Market Impact: 0.25

VTV ETF Factor Report

VTVNDAQ
Company FundamentalsAnalyst InsightsDerivatives & VolatilityHealthcare & Biotech
VTV        ETF Factor Report

Validea's fundamental report on the Vanguard Value ETF (VTV) characterizes it as a Large-Cap Low Volatility ETF, evidenced by its high low volatility factor score of 84. The ETF also exhibits moderate value exposure (score 63) and is primarily concentrated in the Financials sector and Biotechnology & Drugs industry. This breakdown provides institutional investors with a clear understanding of VTV's core factor tilts and sector allocations for portfolio analysis.

Analysis

The Vanguard Value ETF (VTV) is quantitatively profiled as a Large-Cap Low Volatility fund, a characterization strongly substantiated by its high Low Volatility factor score of 84 out of 99. Despite its name, the ETF's exposure to the value factor is moderate, with a score of 63, indicating it is not a pure-play deep value instrument. The fund's other factor exposures are unremarkable, with a middling Quality score of 56 and a weak Momentum score of 46. This factor composition suggests a strategy prioritizing stability over aggressive growth or value-capture. From a portfolio construction perspective, VTV carries a significant concentration in the Financials sector and, more specifically, the Biotechnology & Drugs industry, which are its largest respective allocations.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

Ticker Sentiment

NDAQ0.00
VTV0.00

Key Decisions for Investors

  • Investors should primarily consider VTV as a vehicle to lower portfolio beta and add a defensive tilt, not as a concentrated play on the value factor given its moderate value score.
  • The ETF's low momentum score of 46 indicates it is not suitable for investors seeking to capitalize on market trends and may lag in strongly trending environments.
  • Portfolio managers must account for the fund's substantial exposure to the Financials and Biotechnology sectors to avoid unintended over-concentration and manage sector-specific risks.